| Transdermal iontophoresis for the controlled delivery of therapeutic agents to treat neurodegenerative diseases | |  | | 2012 | 1,063 | 1,673 |
|
| Cutaneous iontophoretic delivery of CGP69669A, a sialyl Lewisx mimetic, in vitro | Experimental dermatology |  | | 2012 | 671 | 0 |
|
| Development and validation of a HPAE-PAD method for the quantification of CGP69669A, a sialyl Lewisx mimetic, in skin permeation studies | BMC. Biomedical chromatography | | | 2012 | 636 | 0 |
|
| Non-invasive iontophoretic delivery of peptides and proteins across the skin | Expert opinion on drug delivery | | | 2011 | 753 | 5 |
|
| Erbium:YAG fractional laser ablation for the percutaneous delivery of intact functional therapeutic antibodies | Journal of controlled release | | | 2011 | 684 | 0 |
|
